HOME ABOUT ▾ library contact order ABOUT NEUROAID ▸ CLINIcal studies ▸ safety profile ▸ Medical Professionals
composition & dosage ▸ Find out if neuroaid is right for you ABOUT NeuroAiD is an oral treatment helping victims of strokes and traumatic brain injuries who suffer from established deficits to recover their functional independence in addition to rehabilitation therapies and exercises. Poster Spotlight: Meta-Analysis on NeuroAiD’s Long-Term Recovery Benefits – APSC 2025

?????? ???????????? ????????? – ???? ????
We are pleased to share the second of two featured posters presented by the Asian Stroke Advisory Panel (ASAP) at the Asia Pacific Stroke Conference (APSC) 2025.

? Poster Title: “Meta-analysis of Effect of MLC601/MLC901 on Long-Term Functional Recovery after Stroke”
? Presenter: Dr. Tsong-Hai Lee
? Date & Time: 14 September 2025 | 10:05–10:45 (GMT+9)
? Session: Post-Stroke and Health Service

This presentation provides a comprehensive meta-analysis of functional recovery outcomes from multiple clinical trials investigating NeuroAiD (MLC601/MLC901) in stroke patients—highlighting their long-term effects on recovery.

We welcome clinicians, researchers, and stroke care professionals to attend the session in Kobe, Japan, and take part in advancing conversations around long-term stroke recovery.

More on APSC 2025: https://apsc2025.umin.jp/
More on ASAP: https://www.asianstrokeadvisory.com/
More on NeuroAiD: www.neuroaid.com